Pathological Inflammation in Patients with COVID-19: a Key Role for Monocytes and Macrophages

Overview

Journal Nat Rev Immunol

Specialty Allergy & Immunology

Date 2020 May 8

PMID 32376901

Citations 1436

Authors

Miriam Merad

Jerome C Martin

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV. Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19.

Citing Articles

Acute Occlusion of a Persistent Sciatic Artery in a Patient with COVID-19 Infection.

Futagami D, Kobayashi T, Morimoto H, Kitaura J, Mukai S, Takahashi S Ann Vasc Dis. 2025; 18(1).

PMID: 40065903 PMC: 11891447. DOI: 10.3400/avd.cr.24-00126.

Early Administration of Bosentan in High-Risk COVID-19 Outpatients at Risk of Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Shahbazi S, Shahbazi E, Zayeri F, Vahdat Shariatpanahi Z J Cachexia Sarcopenia Muscle. 2025; 16(2):e13753.

PMID: 40034063 PMC: 11876846. DOI: 10.1002/jcsm.13753.

Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters.

Rodrigues C, Aulakh G, Kroeker A, Kulkarni S, Lew J, Falzarano D Cell Tissue Res. 2025; .

PMID: 40014090 DOI: 10.1007/s00441-025-03958-2.

A Review of the Hematological Picture of Severe COVID-19 Infection.

Amoroso D, Bongo S, Copponi A, Rossi V, Di Giorgio R, Bernardini S Cureus. 2025; 17(2):e78797.

PMID: 39931501 PMC: 11808344. DOI: 10.7759/cureus.78797.

Clinical applications of human organoids.

Verstegen M, Coppes R, Beghin A, De Coppi P, Gerli M, de Graeff N Nat Med. 2025; 31(2):409-421.

PMID: 39901045 DOI: 10.1038/s41591-024-03489-3.

References

Imai Y, Kuba K, Neely G, Yaghubian-Malhami R, Perkmann T, van Loo G . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2):235-49. PMC: 7112336. DOI: 10.1016/j.cell.2008.02.043. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Ding Y, Wang H, Shen H, Li Z, Geng J, Han H . The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003; 200(3):282-9. PMC: 7168017. DOI: 10.1002/path.1440. View

Owens 3rd A, Passam F, Antoniak S, Marshall S, McDaniel A, Rudel L . Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest. 2012; 122(2):558-68. PMC: 3266787. DOI: 10.1172/JCI58969. View

Gong J, Dong H, Xia Q, Huang Z, Wang D, Zhao Y . Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 2020; 20(1):963. PMC: 7750784. DOI: 10.1186/s12879-020-05681-5. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Berliner J, Watson A . A role for oxidized phospholipids in atherosclerosis. N Engl J Med. 2005; 353(1):9-11. DOI: 10.1056/NEJMp058118. View

Simmons J, Pittet J . The coagulopathy of acute sepsis. Curr Opin Anaesthesiol. 2015; 28(2):227-36. PMC: 4407200. DOI: 10.1097/ACO.0000000000000163. View

Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020; 369(6504):718-724. PMC: 7402632. DOI: 10.1126/science.abc6027. View

10.

Netea M, Joosten L, Latz E, Mills K, Natoli G, Stunnenberg H . Trained immunity: A program of innate immune memory in health and disease. Science. 2016; 352(6284):aaf1098. PMC: 5087274. DOI: 10.1126/science.aaf1098. View

11.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

12.

Chen L, Li X, Chen M, Feng Y, Xiong C . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6):1097-1100. PMC: 7184507. DOI: 10.1093/cvr/cvaa078. View

13.

Serbina N, Pamer E . Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006; 7(3):311-7. DOI: 10.1038/ni1309. View

14.

Cabrera-Benitez N, Laffey J, Parotto M, Spieth P, Villar J, Zhang H . Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology. 2014; 121(1):189-98. PMC: 4991945. DOI: 10.1097/ALN.0000000000000264. View

15.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

16.

Channappanavar R, Fehr A, Vijay R, Mack M, Zhao J, Meyerholz D . Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2):181-93. PMC: 4752723. DOI: 10.1016/j.chom.2016.01.007. View

17.

Iba T, Levy J, Raj A, Warkentin T . Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. J Clin Med. 2019; 8(5). PMC: 6572234. DOI: 10.3390/jcm8050728. View

18.

Sheahan T, Morrison T, Funkhouser W, Uematsu S, Akira S, Baric R . MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog. 2008; 4(12):e1000240. PMC: 2587915. DOI: 10.1371/journal.ppat.1000240. View

19.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

20.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View